Powder Delivery TRIZ Cases

Cerium oxide nanoparticles scavenge hydroxyl and superoxide radicals, preserving mitochondrial membrane potential and preventing Aβ-induced neuronal death.

Oral mucosal delivery bypasses first-pass metabolism to achieve high bioavailability, resolving opioid addiction risks and low absorption rates.

Surface-reacted calcium carbonate replaces nanosized silica to eliminate safety concerns while reducing required dosage for caking prevention.

Specific mutations in conserved residues of callose synthase overcome limited accumulation from wild-type overexpression.

Replacing sugar-based stabilizers with amino acids reduces reconstitution time and viscosity while maintaining long-term stability of protein biomolecules.

Standardized sunflower extract with 50-90% total flavonoids treats hypertension without Western medicine side effects.

Proteolytically degradable nanocapsules protect encapsulated proteins from reactive hydrogel precursors during scaffold incorporation.

Replacing toxic solvents with food-grade oils and lyophilization boosts encapsulation efficiency for hydrophilic drugs.

Peptide sequences bind major histocompatibility complex molecules to stimulate anti-tumor immune responses, reducing chemotherapy side effects.

Biodegradable amino acid polymers release bacteriophages to treat deep wounds without toxic byproducts.

Grinding and sintering produce elongated biocompatible magnetic particles that exert mechanical forces on cancer cells via low-frequency vibration.

Roasting at 90°C to 140°C preserves allergenicity while liquid chromatography controls composition ratios for accurate dosing.

Controlling water content below 2.5% stabilizes the ternary dry powder composition while reducing corticosteroid side effects.

A lyophilized monoclonal antibody formulation stabilizes transthyretin tetramers using optimized excipients.

Nebulized Lactobacillus compositions inhibit inflammatory mediator production, resolving the lack of targeted therapies for bronchopulmonary dysplasia.

Segmented polypeptides bind IgG antibodies to form ordered, monodisperse nanoparticles that resolve manufacturing precision constraints.

Heating lines maintain fat above its melting point before the outlet, preventing solidification clogs and ensuring uniform particle size distribution.

Unmodified graphene oxide adsorbs gadolinium-labeled molecules via co-incubation, resolving synthetic complexity barriers in hydrophilic cargo delivery.

A semi-ordered drug composition with a concentration-enhancing polymer maintains enhanced dissolution performance over time.

Colostrum nasal spray generates an electrostatic field and physical barrier, addressing inadequate viral replication inhibition in the nasal cavity.

A nanoparticle-protein complex enables efficient intracellular delivery of proteins and nucleic acids.

Enteric coating separates acidic ademetionine from unstable cannabidiol, preventing THC formation during storage.

Anti-SEZ6 antibodies target SEZ6 protein on tumor cells, reducing initiating cell frequency and inhibiting recurrence.

Dengue virus serotype 1 targets hypoxic tumor sites to overcome immune evasion mechanisms, reducing cancer cell populations by up to 90%.

A methacrylic copolymer coating provides mechanical stability and controlled release of active pharmaceutical ingredients.

Disaccharide-stabilized freeze-dried tetrodotoxin prevents C-4 hydroxyl epimerization, enabling room temperature storage for over a year.

Encapsulating metal oxide and organic ultraviolet absorbents in a resin matrix prevents recrystallization and discoloration.

Cyclic vacuum evacuation controls effervescent granule reaction kinetics without intermediate drying steps.

Self-assembling ferritin nanocages display high-density epitopes to overcome short peptide limitations and boost immune response.

High-frequency AC fields above 10 kHz replace DC to resolve power efficiency limits while maintaining precise drop size control.

PEGylated gold nanoparticles carrying Phthalocyanine 4 and EGF peptides cross the blood-brain barrier to target brain cancer cells.

Microfluidic mixing produces stable polyplexes, replacing viral vectors to eliminate immunogenicity while enabling scalable manufacturing.

Nanoparticle carriers transport unmodified peptides across the skin barrier, preserving biological activity without chemical modification.

Composite boron-dye nanofiber scaffolds monitor tissue oxygen gradients while maintaining structural integrity through layered design.

Low molecular weight polymers combined with lipids form nanoparticles that deliver siRNA to leukemia cells while reducing cytotoxicity.

A solid solution pharmaceutical composition utilizes a lipid-adjuvant delivery system to transport therapeutic compounds directly to target cells.

Sulfated hyaluronic acid modulates cytokine activity and enhances skin penetration, addressing limited efficacy and side effects of current steroid therapies.

Conjugating ultrasmall nanoparticles with claudin polypeptides enables targeted delivery across the blood brain barrier to regions with altered integrity.

Peptide ligand-conjugated nanoparticles facilitate therapeutic transport across the intestinal epithelium via chylomicron-like structures.

Acetate buffer combined with mannitol and sucrose prevents peptide aggregation and degradation during long-term storage.